Treatment of Intimate Partner Violence and Substance Abuse in a Substance Abuse Treatment Facility

November 3, 2013 updated by: Paul M.G.Emmelkamp, VU University of Amsterdam

Treatment of Intimate Partner Violence and Substance Abuse in a Substance Abuse: a Randomized Controlled Trial

Intimate partner violence is a significant societal problem. There is considerable evidence that a strong relationship between the use of alcohol and other drugs and intimate partner violence exists. Besides, a few studies indicate that reducing substance use may have a positive impact on IPV. Therefore, in this study, patients in substance abuse treatment for the use of alcohol, cannabis or cocaine who also admit to perpetrating intimate partner violence will be randomly assigned to either cognitive behavioral therapy addressing substance abuse combined with treatment for offenders of intimate partner violence or substance abuse treatment alone.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Intimate partner violence is a significant societal problem. However, treatment of IPV perpetrators is far from effective, which may be partly due to the fact that the role of substance abuse is not taken into account. There is considerable evidence that a strong relationship between the use of alcohol and other drugs and intimate partner violence exists. Besides, a few studies indicate that reducing substance use may have a positive impact on IPV. Therefore, in this study, patients in substance abuse treatment for the use of alcohol, cannabis or cocaine who also admit to perpetrating intimate partner violence will be randomly assigned to either cognitive behavioral therapy addressing substance abuse combined with treatment for offenders of intimate partner violence or substance abuse treatment alone.

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Perpetration of intimate partner violence in the past year
  • Substance abuse or dependence (current)
  • Currently in a relationship

Exclusion Criteria:

  • Not sufficient fluency in Dutch to complete treatment and measures
  • (Ab)use of crack cocaine and/or heroin
  • Psychosis
  • Psychopathy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Combined SU/IPV treatment
A combined treatment containing cognitive behavioral therapy addressing partner violence and cognitive behavioral therapy addressing substance abuse
Behavioral: substance abuse/domestic violence treatment
This intervention is comprised of 16 sessions of cognitive behavioral therapy. 8 sessions are addressing partner violence and 8 sessions are addressing substance abuse
Other Names:
  • Treatment for intimate partner violence
  • Treatment for addiction
Active Comparator: control condition
Cognitive behavioral therapy addressing substance abuse
Behavioral: Cognitive behavioral therapy addressing substance abuse
This intervention is comprised of 16 sessions of cognitive behavioral therapy addressing substance abuse.
Other Names:
  • Treatment for addiction

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Substance use: Timeline followback interview (TLFB)
Time Frame: pretest, posttest, 6 & 12 months follow-up
pretest, posttest, 6 & 12 months follow-up
IPV: Conflict Tactics Scale 2 (CTS2)
Time Frame: pretest, halfway treatment, posttest, 6 and 12 months follow-up
pretest, halfway treatment, posttest, 6 and 12 months follow-up

Secondary Outcome Measures

Outcome Measure
Time Frame
Brief Symptom Inventory (BSI)
Time Frame: pretest, posttest
pretest, posttest
Substance use: Quick drinking and drug use screen
Time Frame: Pretest, halfway treatment, posttest, 6 and 12 months follow-up
Pretest, halfway treatment, posttest, 6 and 12 months follow-up
Maudsley Marital Questionnaire (MMQ)
Time Frame: Pretest, posttest, 6 and 12 months follow-up
Pretest, posttest, 6 and 12 months follow-up
Treatment Satisfaction Questionnaire
Time Frame: posttest
posttest

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

VU University of Amsterdam

Investigators

  • Principal Investigator: Paul M. Emmelkamp, PhD., University of Amsterdam

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2009

Primary Completion (Actual)

December 1, 2012

Study Completion (Actual)

June 1, 2013

Study Registration Dates

First Submitted

February 18, 2009

First Submitted That Met QC Criteria

February 18, 2009

First Posted (Estimate)

February 19, 2009

Study Record Updates

Last Update Posted (Estimate)

November 5, 2013

Last Update Submitted That Met QC Criteria

November 3, 2013

Last Verified

November 1, 2013

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2008-KP-466

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance Abuse

Clinical Trials on substance abuse/domestic violence treatment

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe